---
title: "Profound Medical Trial Shows TULSA Improves Prostate Cancer Outcomes"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279064417.md"
description: "Profound Medical Trial Shows TULSA Improves Prostate Cancer Outcomes"
datetime: "2026-03-13T14:58:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279064417.md)
  - [en](https://longbridge.com/en/news/279064417.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279064417.md)
---

# Profound Medical Trial Shows TULSA Improves Prostate Cancer Outcomes

Profound Medical Trial Shows TULSA Improves Prostate Cancer Outcomes

### Related Stocks

- [PROF.US](https://longbridge.com/en/quote/PROF.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)

## Related News & Research

- [Janux Therapeutics Lacking Near-Term Catalysts, UBS Says](https://longbridge.com/en/news/282877328.md)
- [Should Positive Elsunersen Data And Relutrigine Priority Review Shift the Narrative for Praxis (PRAX) Investors?](https://longbridge.com/en/news/282419526.md)
- [Pancreatic cancer pill shown to nearly double overall survival time, drug company says](https://longbridge.com/en/news/282687539.md)
- [Goldman Sachs Sticks to Their Buy Rating for Aclaris Therapeutics (ACRS)](https://longbridge.com/en/news/283014601.md)
- [Mesoblast Secures Exclusive CAR-MSC Technology License; Stock Up](https://longbridge.com/en/news/282790104.md)